132 related articles for article (PubMed ID: 12203372)
1. Reduced Brca1 protein expression in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinomas.
Okochi E; Miyamoto K; Wakazono K; Shima H; Sugimura T; Ushijima T
Mol Carcinog; 2002 Aug; 34(4):211-8. PubMed ID: 12203372
[TBL] [Abstract][Full Text] [Related]
2. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Yu M; Shan L; Snyderwine EG
Oncogene; 2003 Feb; 22(8):1253-60. PubMed ID: 12606953
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
4. Etiology-specific gene expression profiles in rat mammary carcinomas.
Kuramoto T; Morimura K; Yamashita S; Okochi E; Watanabe N; Ohta T; Ohki M; Fukushima S; Sugimura T; Ushijima T
Cancer Res; 2002 Jul; 62(13):3592-7. PubMed ID: 12097258
[TBL] [Abstract][Full Text] [Related]
5. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Toyota M; Ushijima T; Weisburger JH; Hosoya Y; Canzian F; Rivenson A; Imai K; Sugimura T; Nagao M
Mol Carcinog; 1996 Mar; 15(3):176-82. PubMed ID: 8597530
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide instability without microsatellite instability in rat mammary carcinomas.
Watanabe N; Okochi E; Hirayama Y; Shimada Y; Yanagihara K; Yoshida MC; Takahashi S; Mochizuki M; Sugimura T; Nagao M; Ushijima T
Cancer Res; 2001 Mar; 61(6):2632-40. PubMed ID: 11289141
[TBL] [Abstract][Full Text] [Related]
9. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and apoptosis in PhIP-induced rat mammary gland carcinomas with elevated phosphotyrosine-STAT5a.
Papaconstantinou AD; Snyderwine EG
FEBS Lett; 2007 Jan; 581(1):29-33. PubMed ID: 17173897
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
[TBL] [Abstract][Full Text] [Related]
14. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
15. Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.
Yu M; Ryu DY; Snyderwine EG
Mol Carcinog; 2000 Feb; 27(2):76-83. PubMed ID: 10657900
[TBL] [Abstract][Full Text] [Related]
16. Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats.
Nagao M; Ushijima T; Watanabe N; Okochi E; Ochiai M; Nakagama H; Sugimura T
Environ Mol Mutagen; 2002; 39(2-3):158-64. PubMed ID: 11921184
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
18. Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model.
Doi K; Hagihara A; Wei M; Yunoki T; Fukushima S; Wanibuchi H
Oncology; 2007; 73(3-4):252-60. PubMed ID: 18424890
[TBL] [Abstract][Full Text] [Related]
19. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
20. The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.
Garcia V; García JM; Peña C; Silva J; Domínguez G; Rodríguez R; Maximiano C; Espinosa R; España P; Bonilla F
J Pathol; 2005 May; 206(1):92-9. PubMed ID: 15772983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
